Intrepid Financial Planning Group LLC
- SEC CIK
- 0001641296
- Latest filing
- Aug 12, 2026
ATNM holding history
Actinium Pharmaceuticals, Inc. in every 13F filed by Intrepid Financial Planning Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −10,500−100.0% | Sold out | Holders |
| Q1 2026 | 10,500 | $10.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 10,500 | $14.3K | <0.1% | −2,000−16.0% | Reduced | Holders |
| Q3 2025 | 12,500 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 12,500 | $17.5K | <0.1% | −2,000−13.8% | Reduced | Holders |
| Q1 2025 | 14,500 | $23.3K | <0.1% | +500+3.6% | Added | Holders |
| Q4 2024 | 14,000 | $17.6K | <0.1% | −5,000−26.3% | Reduced | Holders |
| Q3 2024 | 19,000 | $35.7K | <0.1% | −1,000−5.0% | Reduced | Holders |
| Q2 2024 | 20,000 | $148.0K | 0.1% | +4,000+25.0% | Added | Holders |
| Q1 2024 | 16,000 | $125.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 16,000 | $81.3K | <0.1% | −2,000−11.1% | Reduced | Holders |
| Q3 2023 | 18,000 | $106.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 18,000 | $133.6K | 0.1% | −1,000−5.3% | Reduced | Holders |
| Q1 2023 | 19,000 | $179.6K | 0.1% | −1,000−5.0% | Reduced | Holders |
| Q4 2022 | 20,000 | $213.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 20,000 | $148.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 20,000 | $96.0K | 0.1% | – | No prior filing | Holders |